SCHEMBL29816896

SCHEMBL29816896

O=C1CCN(c2cc(C(=O)N3CCC(OC4CCNCC4)CC3)ccc2Cl)C(=O)N1

nearest known ligand 0.39

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ MGLL Q99685 4/20 0.39
▸ HSD11B1 P28845 2/20 0.39
▸ BCL9 O00512 4/20 0.38
▸ CTNNB1 P35222 4/20 0.38
▸ TSHR P16473 1/20 0.38
▸ HPGD P15428 1/20 0.37
▸ L3MBTL3 Q96JM7 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ LRRK2 Q5S007 1/20 0.36
▸ MAPK14 Q16539 1/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36
▸ DDB1 Q16531 1/20 0.35
▸ CRBN Q96SW2 1/20 0.35
▸ HRH1 P35367 1/20 0.35
▸ CCR3 P51677 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23120508 1.00 MGLL (0.39) MGLLHSD11B1BCL9CTNNB1TSHR
Hydrochloric Acid SCHEMBL30009287 0.99 BCL9 (0.40) MGLLHSD11B1BCL9CTNNB1TSHR
Hydrochloric Acid SCHEMBL23121732 0.99 BCL9 (0.40) MGLLHSD11B1BCL9CTNNB1TSHR
SCHEMBL23121109 0.91 MGLL (0.40) MGLLHSD11B1TSHRHPGDLRRK2
SCHEMBL31255252 0.89 MAPT (0.43) MGLLHSD11B1TSHRHPGDHRH1
SCHEMBL23122011 0.88 GFER (0.44) HSD11B1BCL9CTNNB1HPGDL3MBTL3
SCHEMBL30009532 0.88 GFER (0.44) HSD11B1BCL9CTNNB1HPGDL3MBTL3
SCHEMBL23122009 0.88 HSD11B1 (0.37) MGLLHSD11B1BCL9CTNNB1TSHR
SCHEMBL30008961 0.88 HSD11B1 (0.37) MGLLHSD11B1BCL9CTNNB1TSHR
Hydrochloric Acid SCHEMBL23121683 0.87 GFER (0.43) HSD11B1BCL9CTNNB1HPGDL3MBTL3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4041724-A1 BRD9 BIFUNCTIONAL DEGRADERS AND THEIR METHODS OF USE Novartis AG (CH) 2022-08-17 — — EP disclosed
EP-4031247-A1 BIFUNCTIONAL DEGRADERS AND THEIR METHODS OF USE Novartis AG (CH) 2022-07-27 — — EP disclosed
Send feedback